Myriad Genetics Inc (MYGN)
US$ 14.88-1.65%
Price Chart
Key Statistics
Market Cap
$ 410.19M
P/E Ratio
0.00
Revenue (TTM)
$ 831.3M
Volume
1.06M
52W High
$ 29.30
52W Low
$ 3.81
Dividend Yield
0.00%
Beta
2.02
Technicals
50-Day MA
7.648
200-Day MA
16.3
52 Week High
29.3
52 Week Low
3.8119
About MYGN
Myriad Genetics, Inc., a molecular diagnostic testing and precision medicine company, develops and provides molecular tests in the United States and internationally.
Employees
2700
Headquarters
Salt Lake City, UT
CEO
Mr. Samraat S. Raha
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg